Biotechnology Stock Doubled This: Fund Bets 1.2M Shares
A large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
Take advantage of free courses on financial planning for beginners to boost your financial knowledge. Start your learning journey today.
14,750 articlesA large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
A major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
Markets have been rallying, but a flashing warning sign could signal trouble ahead. This guide explains what to watch...
A major fund recently reduced its exposure to Adaptive Biotechnologies, sparking questions about what institutional m...
A new wave of crypto treasury firms, including ethereum firm sharplink and Solana-focused treasuries, could land in R...
Bitcoin plunged to multi-week lows as traders priced in renewed tensions between the U.S. and Iran, triggering massiv...
A new AI-based forecast points to a sharp XRP rally by end-2026, with potential moves beyond current ranges as regula...
In a volatile energy market, two durable picks stand out as no-brainer energy stocks right for many portfolios. Learn...
XRP faces a staged path to higher levels, with Standard Chartered outlining a first milestone near $4 before targetin...
XRP retreats as liquidity shifts and traders weigh a major XRP Ledger upgrade. This ripple news price update outlines...
XRP fell roughly 5% over the past seven days, pulling back from a short-lived bounce as traders weigh catalysts for a...
A fresh stake in COPT Defense Properties signals a calculated tilt toward defense-related real estate. This article b...